Dr. Ben Shields and Dr. Matt McCormack, Walter and Eliza Hall Institute (image) Walter and Eliza Hall Institute Share Print E-Mail Caption Researchers from the Walter and Eliza Hall Institute in Melbourne, Australia, have shown they can stop leukaemia in its tracks by targeting a protein that puts the handbrake on cancer cell growth. The researchers discovered that targeting a protein called Hhex could cure acute myeloid leukaemia (AML) in preclinical disease models, and could be a key target for new therapies for human leukaemia. Credit Walter and Eliza Hall Institute Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.